Australia markets closed
  • ALL ORDS

    7,536.10
    -21.70 (-0.29%)
     
  • AUD/USD

    0.7107
    -0.0001 (-0.02%)
     
  • ASX 200

    7,225.20
    -10.70 (-0.15%)
     
  • OIL

    67.19
    +1.62 (+2.47%)
     
  • GOLD

    1,773.20
    -11.10 (-0.62%)
     
  • BTC-AUD

    79,849.45
    -1,164.08 (-1.44%)
     
  • CMC Crypto 200

    1,448.31
    -20.77 (-1.41%)
     

Is Moderna a Good Healthcare Stock to Buy Now?

·3-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Moderna's (NASDAQ: MRNA) COVID-19 vaccine has created a multibillion-dollar revenue stream for the company, but is the massive $130 billion valuation of the business justified? In this Fool Live video clip, recorded on Oct. 4, Fool.com contributors Rachel Warren and Jason Hall discuss whether Moderna could be a smart buy despite its nosebleed-level valuation. Rachel Warren: It's funny, because I write about healthcare stocks a lot and I'm a healthcare writer here at the Fool.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting